Skip to main content

AusPAR: Adalimumab

Australian Public Assessment Report
Device/Product Name
Humira
Active ingredients
Adalimumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2013-01154-1-1
Submission Type
Extension of indications, New strength
Decision
Approved

Help us improve the Therapeutic Goods Administration site